• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Assessment of quantitative spectral Doppler parameters; resistivity index (RI) and acceleration time (AT) together to show their reliability for differential diagnosis of parenchymal thyroid diseases

    Dr. Aditya Kaul, Dr. Monika Sharma, Dr. Sidhant Lochav, Dr. Govind Khatri, Dr. Bhawna Sandhir, Dr. Ankitaa Thakral

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1124-1129

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim:To assess some quantitative spectral Doppler parameters, resistivity index (RI) and
acceleration time (AT) together to show their reliability for differential diagnosis of
parenchymal thyroid diseases.
Methods: This study was conducted in the Department of Radiology, Maharishi
Markandeshwar University, Solanfor the period of 1 year. Patientsweredivided into five
groups such as group I (normal); group II had first detected, early untreated Hashimoto
disease(EH);groupIII comprised of chronic Hashimoto patients that are under treatment
and/or follow up (H); group IV had multinodular parenchymal hyperplasia (M) and group V
had nodular hyperplasia with Hashimoto (HM). They underwent spectral Dopplerultrasound
usingPhilipsAfiniti 70 G machine by a linear 5-12 MHz probe. Quantitative spectral Doppler
parameters such as resistivity index (RI) and acceleration time (AT) were recorded.
Results: Out of 200, 62.5% were female and 37.5% male most of the patients between 30-40
years 42.5% and followed by 40-50 years was 30%. The distribution of patients was done
based on diseases. The mean RI in group I was 0.57, in group II was 0.60, in group III was
0.45, in group IV was 0.51 and in group V was 0.53. Mean AT in group I was 25.9, in group
II was 24.8, in group III was 69.5, in group IV was 45.8 and in group V was 44.5.The
difference was significant (P< 0.05).
Conclusion: The resistivity index and acceleration time together are reliable for differential
diagnosis of parenchymal thyroid diseases.
Keywords:
    hashimoto disease Thyroid gland Ultrasonography
  • PDF (504 K)
  • XML
(2022). Assessment of quantitative spectral Doppler parameters; resistivity index (RI) and acceleration time (AT) together to show their reliability for differential diagnosis of parenchymal thyroid diseases. European Journal of Molecular & Clinical Medicine, 9(1), 1124-1129.
Dr. Aditya Kaul, Dr. Monika Sharma, Dr. Sidhant Lochav, Dr. Govind Khatri, Dr. Bhawna Sandhir, Dr. Ankitaa Thakral. "Assessment of quantitative spectral Doppler parameters; resistivity index (RI) and acceleration time (AT) together to show their reliability for differential diagnosis of parenchymal thyroid diseases". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1124-1129.
(2022). 'Assessment of quantitative spectral Doppler parameters; resistivity index (RI) and acceleration time (AT) together to show their reliability for differential diagnosis of parenchymal thyroid diseases', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1124-1129.
Assessment of quantitative spectral Doppler parameters; resistivity index (RI) and acceleration time (AT) together to show their reliability for differential diagnosis of parenchymal thyroid diseases. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1124-1129.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 80
  • PDF Download: 101
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus